Search

Your search keyword '"Kaufmann, Manfred"' showing total 10 results
Start Over Author "Kaufmann, Manfred" Journal breast care
10 results on '"Kaufmann, Manfred"'

2. Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

Author

Untch, Michael, primary, Gerber, Bernd, additional, Möbus, Volker, additional, Schneeweiss, Andreas, additional, Thomssen, Christoph, additional, von Minckwitz, Gunter, additional, Beckmann, Matthias W., additional, Blohmer, Jens-Uwe, additional, Costa, Serban-Dan, additional, Diedrich, Klaus, additional, Diel, Ingo, additional, Eiermann, Wolfgang, additional, Friese, Klaus, additional, Harbeck, Nadia, additional, Hilfrich, Jörn, additional, Jackisch, Christian, additional, Janni, Wolfgang, additional, Jänicke, Fritz, additional, Jonat, Walter, additional, Kaufmann, Manfred, additional, Kiechle, Marion, additional, Köhler, Uwe, additional, Kreienberg, Rolf, additional, Maass, Nicolai, additional, Marschner, Norbert, additional, Nitz, Ulrike, additional, Scharl, Anton, additional, and Wallwiener, Diethelm, additional

Published
2011
Full Text
View/download PDF

3. Breast Cancer Proteomics – Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag Technology

Author

Ruckhäberle, Eugen, primary, Karn, Thomas, additional, Hanker, Lars, additional, Schwarz, Josef, additional, Schulz-Knappe, Peter, additional, Kuhn, Karsten, additional, Böhm, Gitte, additional, Selzer, Stefan, additional, Neukum, Erhard, additional, Engels, Knut, additional, Holtrich, Uwe, additional, Kaufmann, Manfred, additional, and Rody, Achim, additional

Published
2010
Full Text
View/download PDF

4. Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer)

Author

Beckmann, Matthias W., primary, Blohmer, Jens-Uwe, additional, Costa, Serban-Dan, additional, Diedrich, Klaus, additional, Diel, Ingo, additional, Eiermann, Wolfgang, additional, Friese, Klaus, additional, Gerber, Bernd, additional, Harbeck, Nadia, additional, Hilfrich, Joern, additional, Janni, Wolfgang, additional, Jaenicke, Fritz, additional, Jonat, Walter, additional, Kaufmann, Manfred, additional, Kiechle, Marion, additional, Koehler, Uwe, additional, Kreienberg, Rolf, additional, von Minckwitz, Gunter, additional, Moebus, Volker, additional, Nitz, Ulrike, additional, Schneeweiss, Andreas, additional, Thomssen, Christoph, additional, and Wallwiener, Diethelm, additional

Published
2009
Full Text
View/download PDF

7. AGO Recommendations for the Diagnosis and Therapy of Breast Cancer

Author

Thomssen, Christoph, primary, Bauerfeind, Ingo, additional, Bischoff, Joachim, additional, Blohmer, Jens Uwe, additional, Brunnert, Klaus, additional, Costa, Serban D., additional, Dall, Peter, additional, Diel, Ingo J., additional, Fersis, Nikos, additional, Friedrich, Michael, additional, Friedrichs, Kay, additional, Gerber, Bernd, additional, Göhring, Uwe-Jochen, additional, Hanf, Volker, additional, Harbeck, Nadia, additional, Huober, Jens, additional, Jackisch, Christian, additional, Janni, Wolfgang, additional, Jonat, Walter, additional, Kaufmann, Manfred, additional, Lück, Hans-Joachim, additional, Maass, Nicolai, additional, Möbus, Volker, additional, Nitz, Ulrike, additional, Oberhoff, Carsten, additional, Rezai, Mahdi, additional, Schaller, Gerhard, additional, Scharl, Anton, additional, Schmutzler, Rita, additional, Schneeweiss, Andreas, additional, Schreer, Ingrid, additional, Kreipe, H., additional, Sinn, Peter, additional, Solomayer, Erich F., additional, Souchon, Rainer, additional, Stickeler, Elmar, additional, Thomssen, Christoph, additional, Untch, Michael, additional, and von Minckwitz, Gunter, additional

Published
2007
Full Text
View/download PDF

9. Prevention Trials in Women at Moderate Risk of Breast Cancer.

Author

von Minckwitz, Gunter, Loibl, Sibylle, Gimeno, Silvia, Segura-Eicke, Patricia, Eiermann, Wolfgang, and Kaufmann, Manfred

Subjects
BREAST cancer, CANCER in women, ADJUVANT treatment of cancer, CLINICAL trials, WOMEN'S health, ESTROGEN antagonists, STEROID hormones, MEDICAL experimentation on humans
Abstract

The primary goal of most protocols of past and present mammary cancer clinical trials is the reduction of breast cancer incidence. The assumption that the selective estrogen receptor modulator (SERM) tamoxifen could prevent mammary cancer resulted from the experience obtained in palliative and adjuvant treatments. Several prevention clinical trials involve this SERM, e.g. P1, IBIS I, Royal Marsden Hospital Tamoxifen Prevention Trial, Italian Randomized Trial Among Hysterectomized Women. Second-generation trials tested other types of substances, such as aromatase inhibitors which were included in the IBIS II trial. Other trials investigate alternative SERMs, such as raloxifene, arzoxifene and lasofoxifene, as well as endocrine substances, such as gonadotropinreleasing hormone agonists and enzyme inhibitors (e.g. Cox-2 cyclooxigenases). [ABSTRACT FROM AUTHOR]

Published
2006
Full Text
View/download PDF

10. Predictive and Prognostic Markers in Breast Cancer Treatment Presentations at the 28th San Antonio Breast Cancer Symposium 2005.

Author

Rody, Achim, Karn, Thomas, and Kaufmann, Manfred

Subjects
BREAST cancer, CANCER treatment, GENE expression, TUMORS, TUMOR markers, CLINICAL trials
Abstract

The increasing understanding of the pathophysiological background of breast cancer is associated with new molecular techniques, improved risk assessment, targeted therapy and individualized treatment. Gene expression profiling may provide predictive and prognostic gene signatures which could help characterize tumors and enable more tailored therapies. Beyond this, gene expression profiling allows us to better understand tumor development and can help identify new molecular markers which should be investigated in terms of specific clinical objectives. There is also an increasing trend towards translational research in large clinical trials which gives new insight into pathophysiology and the prediction of response according to specific therapeutic approaches. Even if the detection of new molecular markers gives rise to new hypotheses, most studies lack a prospective setting, and thus the use of identified markers or specific gene signatures in clinical routine is still limited. [ABSTRACT FROM AUTHOR]

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results